CooperSurgical and Fulgent partner on newborn genetic screening panels
The collaboration leverages Fulgent's Picture Genetics platform to offer genetic testing options through CooperSurgical’s Cord Blood Registry (CBR).
12 February 2024
12 February 2024
The collaboration leverages Fulgent's Picture Genetics platform to offer genetic testing options through CooperSurgical’s Cord Blood Registry (CBR).
The certification indicates that the product complies with the EU's Medical Devices Regulation (EU) 2017/745.
Biogen will transfer ownership of certain digital health solutions to Aptar.
The new sticker can monitor deep internal organs' stiffness to help identify early signs of diseases such as acute liver failure.
Philips' has recalled a number of high profile medical devices in recent years, shaking investor confidence.
MIVI presented positive data from the study at the 2024 International Stroke Conference in Phoenix, Arizona, US, on 8 February.
The smart implant would be designed to help surgeons select the best implant size for joint stability and mobility.
The test, designed to identify if the user’s gonorrhoea is susceptible to antibiotics, was launched in collaboration with a US non-profit aiming to cut the threat of antibiotic resistant bacteria.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.